Evaluating nipocalimab for the treatment of chronic inflammatory demyelinating polyneuropathy
- Published on 05/29/2026
- Reading time: 1 min.
Kazumoto Shibuya a,* , Kazuaki Kito a , Tomoki Suichi a , Sonoko Misawa a,b & Satoshi Kuwabara a
a Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
b Department of Neurology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan
CONTACT Kazumoto Shibuya mailto:kazumoto@net.email.ne.jp Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Rare Diseases
Receive our newsletter to stay up to date with the latest news in Rare Diseases




